According to Hester Biosciences latest financial reports the cash on hand of HESTERBIO is $1.64M, an decrease of -45.29% to 2022. At the end of 2022 company had $3.01M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.64M | -45.29% |
2022 | $3.01M | 19.53% |
2021 | $2.52M | -9.78% |
2020 | $2.79M | -43.87% |
2019 | $4.97M | - |